Washington, D.C. – September 29, 2026 -- LUNGevity Foundation has committed $2 million to fund two three-year clinical research projects aimed at improving the diagnosis of indeterminate pulmonary nodules (IPNs), a condition affecting more than 1.5 million Americans annually after routine chest CT scans.

San Francisco – September 29, 2026 -- Innovent Biologics reported an 84.6% overall response rate for its trispecific antibody IBI3003 at the recommended Phase 2 dose in heavily pretreated multiple myeloma patients, data presented in an oral session at the 23rd International Myeloma Society Annual Meeting 2026.

London – September 29, 2026 -- Pearson (FTSE: PSON.L) has agreed to acquire Workera, an AI-native skills intelligence platform used by enterprises including ServiceNow, Accenture and the United States Space Force to verify workforce capability.

Taipei – – September 29, 2026 -- ORing Industrial Networking, a Taiwan-based industrial networking specialist with 20 years of market experience, showcased its next-generation IRoN railway Ethernet switch portfolio at InnoTrans 2026.

Washington D.C. – September 29, 2026 -- Implantica AG launched its FDA-approved RefluxStop device in the U.S. market at the American Foregut Society (AFS) 2026 Annual Meeting, drawing an over-capacity crowd of more than 120 surgeons and gastroenterologists that forced organizers to turn away additional attendees.

Indianapolis – September 29, 2026 -- Eli Lilly and Company (NYSE: LLY) reported that its oral GLP-1 drug Foundayo (orforglipron) at 17.2 mg produced 1.5% greater weight loss and 0.3% greater A1C reduction than oral semaglutide 25 mg over 52 weeks in adults with type 2 diabetes, based on an indirect treatment comparison presented at the 62nd Annual Meeting of the European Association for the Study of Diabetes in Milan.

Oslo, Norway – September 29, 2026 -- Nel ASA has secured a purchase order worth approximately USD 12 million from Collins Aerospace for PEM electrolyser stacks destined for US Navy submarine life-support systems. The order was placed through Nel Hydrogen US, a subsidiary of the Oslo-listed hydrogen technology company (OSE: NEL).

Los Angeles – September 29, 2026 -- Explore The Trades, a Minnesota-based nonprofit founded in 2005, has placed classroom poster kits reaching more than 1.3 million students since 2021 across over 3,400 U.S. school districts, roughly a quarter of the country, as part of a national push to rebuild the plumbing, HVAC, and electrical talent pipeline.

Irvine, Calif. – – September 29, 2026 -- Performance Brokerage Services has brokered the sale of Genesis of Glenview, Illinois, to Joe Ghaben, adding a fifth franchise point to the Chicago-area Ghaben Auto Group.

Ghaben Auto Group expands Chicago footprint with Genesis acquisition

Ghaben Auto Group, founded in 2004, already operates Volkswagen of Oak Lawn, Volkswagen of Orland Park, and the two-location Ultimo Motors luxury pre-owned brand in Northbrook and Westmont. The Genesis acquisition marks the group's entry into the Genesis franchise network.

Chengdu, China – September 29, 2026 -- iRegene Therapeutics has secured clinical trial clearances in both China and the United States for NouvSight001, an off-the-shelf cell therapy targeting retinitis pigmentosa (RP), a retinal disease affecting roughly 1.5 million people worldwide.